Randomized Phase 1 Study of Sequential (“Primed”) vs. Concurrent Decitabine in Combination with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm

অনুরূপ উপাদানগুলি

• Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
  অনুযায়ী: Halpern, Anna B., অন্যান্য
  প্রকাশিত: (2019)
• Mitoxantrone, Etoposide, and Cytarabine (MEC) Following Epigenetic Priming with Decitabine in Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms: A Phase 1/2 Study
  অনুযায়ী: Halpern, Anna B., অন্যান্য
  প্রকাশিত: (2017)
• Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
  অনুযায়ী: Ciera L. Patzke, অন্যান্য
  প্রকাশিত: (2020-02-01)
• Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
  অনুযায়ী: Patzke, Ciera L., অন্যান্য
  প্রকাশিত: (2020)
• CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia
  অনুযায়ী: Halpern, Anna B., অন্যান্য
  প্রকাশিত: (2018)